4//SEC Filing
Rothbard Jonathan B. 4
Accession 0001213900-23-075375
CIK 0001690080other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 4:00 PM ET
Size
6.5 KB
Accession
0001213900-23-075375
Insider Transaction Report
Form 4
Rothbard Jonathan B.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-09-04+15,000→ 15,000 totalExercise: $0.67Exp: 2033-09-04→ Common Stock (15,000 underlying)
Holdings
- 28,023
Common Stock
Footnotes (2)
- [F1]The Stock Options were granted to the Reporting Person pursuant to the Issuer's First Amended and Restated 2022 Omnibus Incentive Plan in consideration for services to be rendered as Chief Scientific Officer. Exempt from Section 16(b) pursuant to Rule 16b-3.
- [F2]The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001833968
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 4:00 PM ET
- Size
- 6.5 KB